MicroRNA-155 regulates T cell proliferation through targeting GSK3β in cardiac allograft rejection in a murine transplantation model

Cellular Immunology

Volumn 281, Issue 2, 2013, Pages 141-149

  Feng, Zhiyu ^a,b   Xia, Yu ^a   Zhang, Mingjie ^a   Zheng, Jinghao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b QILU CHILDREN S HOSPITAL OF SHANDONG UNIVERSITY   (China)

Author keywords

Allograft rejection; GSK3 ; Microrna 155

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; GLYCOGEN SYNTHASE KINASE 3BETA; LUCIFERASE; MICRORNA 155; MICRORNA 155 INHIBITOR; PROTEIN SERINE THREONINE KINASE INHIBITOR; TWS 119; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD; CARDIAC GRAFT REJECTION; CELL ISOLATION; CONTROLLED STUDY; FEASIBILITY STUDY; GENE EXPRESSION; GENE TARGETING; GRAFT INFILTRATING LYMPHOCYTE; GROWTH INHIBITION; HEART TRANSPLANTATION; ISOGRAFT; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MALE; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; SPLEEN; T LYMPHOCYTE;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION PROFILING; GLYCOGEN SYNTHASE KINASE 3; GRAFT REJECTION; HEART TRANSPLANTATION; HEK293 CELLS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICRORNAS; MODELS, ANIMAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 84877339509     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2013.04.001     Document Type: Article

References (44)

1. Roger V.L., Go A.S., Lloyd-Jones D.M., Benjamin E.J., Berry J.D., Borden W.B., Bravata D.M., Dai S., Ford E.S., Fox C.S., Fullerton H.J., Gillespie C., Hailpern S.M., Heit J.A., Howard V.J., Kissela B.M., Kittner S.J., Lackland D.T., Lichtman J.H., Lisabeth L.D., Makuc D.M., Marcus G.M., Marelli A., Matchar D.B., Moy C.S., Mozaffarian D., Mussolino M.E., Nichol G., Paynter N.P., Soliman E.Z., Sorlie P.D., Sotoodehnia N., Turan T.N., Virani S.S., Wong N.D., Woo D., Turner M.B. American Heart Association statistics, s. stroke statistics, heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012, 125:e2-e220.
2. Stehlik J., Edwards L.B., Kucheryavaya A.Y., Benden C., Christie J.D., Dobbels F., Kirk R., Rahmel A.O., Hertz M.I. The registry of the international society for heart and lung transplantation: twenty-eighth adult heart transplant report-2011. The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation 2011, 30:1078-1094.
3. Raichlin E., Edwards B.S., Kremers W.K., Clavell A.L., Rodeheffer R.J., Frantz R.P., Pereira N.L., Daly R.C., McGregor C.G., Lerman A., Kushwaha S.S. Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantation. The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation 2009, 28:320-327.
4. Pilat N., Sayegh M.H., Wekerle T. Costimulatory pathways in transplantation. Seminars in Immunology 2011, 23:293-303.
5. Golshayan D., Wyss J.C., Buckland M., Hernandez-Fuentes M., Lechler R.I. Differential role of naive and memory CD4 T-cell subsets in primary alloresponses. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2010, 10:1749-1759.
6. Ingulli E. Mechanism of cellular rejection in transplantation. Pediatric Nephrology 2010, 25:61-74.
7. Yamamoto M., Kondo E., Takeuchi M., Harashima A., Otani T., Tsuji-Takayama K., Yamasaki F., Kumon H., Kibata M., Nakamura S. MiR-155, a modulator of FOXO3a protein expression is underexpressed and cannot be upregulated by stimulation of HOZOT, a line of multifunctional Treg. PloS One 2011, 6:e16841.
8. Anglicheau D., Sharma V.K., Ding R., Hummel A., Snopkowski C., Dadhania D., Seshan S.V., Suthanthiran M. MicroRNA expression profiles predictive of human renal allograft status. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:5330-5335.
9. Thiele S., Wittmann J., Jack H.M., Pahl A. MiR-9 enhances IL-2 production in activated human CD4(+) T cells by repressing Blimp-1. European Journal of Immunology 2012, 42:2100-2108.
10. Jiang S., Li C., Olive V., Lykken E., Feng F., Sevilla J., Wan Y., He L., Li Q.J. Molecular dissection of the miR-17-92 cluster's critical dual roles in promoting Th1 responses and preventing inducible Treg differentiation. Blood 2011, 118:5487-5497.
11. Zampetaki A., Willeit P., Tilling L., Drozdov I., Prokopi M., Renard J.M., Mayr A., Weger S., Schett G., Shah A., Boulanger C.M., Willeit J., Chowienczyk P.J., Kiechl S., Mayr M. Prospective study on circulating MicroRNAs and risk of myocardial infarction. Journal of the American College of Cardiology 2012, 60:290-299.
12. Grigoryev Y.A., Kurian S.M., Hart T., Nakorchevsky A.A., Chen C., Campbell D., Head S.R., Yates J.R., Salomon D.R. MicroRNA regulation of molecular networks mapped by global microRNA, mRNA, and protein expression in activated T lymphocytes. Journal of Immunology 2011, 187:2233-2243.
13. + T cells. European Journal of Immunology 2010, 40:225-231.
14. Murugaiyan G., Beynon V., Mittal A., Joller N., Weiner H.L. Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis. Journal of Immunology 2011, 187:2213-2221.
15. Ranganathan P., Heaphy C.E., Costinean S., Stauffer N., Na C., Hamadani M., Santhanam R., Mao C., Taylor P.A., Sandhu S., He G., Shana'ah A., Nuovo G.J., Lagana A., Cascione L., Obad S., Broom O., Kauppinen S., Byrd J.C., Caligiuri M., Perrotti D., Hadley G.A., Marcucci G., Devine S.M., Blazar B.R., Croce C.M., Garzon R. Regulation of acute graft-versus-host disease by microRNA-155. Blood 2012, 119:4786-4797.
16. Wei L., Wang M., Qu X., Mah A., Xiong X., Harris A.G., Phillips L.K., Martinez O.M., Krams S.M. Differential expression of microRNAs during allograft rejection. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2012, 12:1113-1123.
17. Asaoka T., Sotolongo B., Island E.R., Tryphonopoulos P., Selvaggi G., Moon J., Tekin A., Amador A., Levi D.M., Garcia J., Smith L., Nishida S., Weppler D., Tzakis A.G., Ruiz P. MicroRNA signature of intestinal acute cellular rejection in formalin-fixed paraffin-embedded mucosal biopsies. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2012, 12:458-468.
18. Sun Y., Wang M., Lin G., Sun S., Li X., Qi J., Li J. Serum MicroRNA-155 as a potential biomarker to track disease in breast cancer. PloS One 2012, 7:e47003.
19. Wang J., Chen J., Chang P., LeBlanc A., Li D., Abbruzzesse J.L., Frazier M.L., Killary A.M., Sen S. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prevention Research 2009, 2:807-813.
20. Cortes-Vieyra R., Bravo-Patino A., Valdez-Alarcon J.J., Cajero Juarez M., Finlay B.B., Baizabal-Aguirre V.M. Role of glycogen synthase kinase-3 beta in the inflammatory response caused by bacterial pathogens. Journal of Inflammation 2012, 9:23.
21. Wang H., Brown J., Martin M. Glycogen synthase kinase 3: a point of convergence for the host inflammatory response. Cytokine 2011, 53:130-140.
22. Jope R.S., Yuskaitis C.J., Beurel E. Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochemical Research 2007, 32:577-595.
23. Niimi M. The technique for heterotopic cardiac transplantation in mice: experience of 3000 operations by one surgeon. The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation 2001, 20:1123-1128.
24. Liu F., Kang S.M. Heterotopic heart transplantation in mice. Journal of Visualized Experiments: JoVE 2007, 4:238.
25. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
26. Chen L., Ahmed E., Wang T., Wang Y., Ochando J., Chong A.S., Alegre M.L. TLR signals promote IL-6/IL-17-dependent transplant rejection. Journal of Immunology 2009, 182:6217-6225.
27. Zhao X., Boenisch O., Yeung M., Mfarrej B., Yang S., Turka L.A., Sayegh M.H., Iacomini J., Yuan X. Critical role of proinflammatory cytokine IL-6 in allograft rejection and tolerance. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2012, 12:90-101.
28. Doenst T., Schlensak C., Kobba J.L., Beyersdorf F. A technique of heterotopic, infrarenal heart transplantation with double anastomosis in mice. The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation 2001, 20:762-765.
29. Stewart S., Winters G.L., Fishbein M.C., Tazelaar H.D., Kobashigawa J., Abrams J., Andersen C.B., Angelini A., Berry G.J., Burke M.M., Demetris A.J., Hammond E., Itescu S., Marboe C.C., McManus B., Reed E.F., Reinsmoen N.L., Rodriguez E.R., Rose A.G., Rose M., Suciu-Focia N., Zeevi A., Billingham M.E. Revision of the working formulation for the standardization of nomenclature in the diagnosis of heart rejection. The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation 1990, 24(2005):1710-1720.
30. Beier U.H., Wang L., Bhatti T.R., Liu Y., Han R., Ge G., Hancock W.W. Sirtuin-1 targeting promotes Foxp3+ T-regulatory cell function and prolongs allograft survival. Molecular and Cellular Biology 2011, 31:1022-1029.
31. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., Peterson A., Noteboom J., O'Briant K.C., Allen A., Lin D.W., Urban N., Drescher C.W., Knudsen B.S., Stirewalt D.L., Gentleman R., Vessella R.L., Nelson P.S., Martin D.B., Tewari M. Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:10513-10518.
32. Hennessey P.T., Sanford T., Choudhary A., Mydlarz W.W., Brown D., Adai A.T., Ochs M.F., Ahrendt S.A., Mambo E., Califano J.A. Serum microRNA biomarkers for detection of non-small cell lung cancer. PloS One 2012, 7:e32307.
33. Itoh S., Kimura N., Axtell R.C., Velotta J.B., Gong Y., Wang X., Kajiwara N., Nambu A., Shimura E., Adachi H., Iwakura Y., Saito H., Okumura K., Sudo K., Steinman L., Robbins R.C., Nakae S., Fischbein M.P. Interleukin-17 accelerates allograft rejection by suppressing regulatory T cell expansion. Circulation 2011, 124:S187-196.
34. Antonysamy M.A., Fanslow W.C., Fu F., Li W., Qian S., Troutt A.B., Thomson A.W. Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors. Journal of Immunology 1999, 162:577-584.
35. Chen Y., Wood K.J. Interleukin-23 and TH17 cells in transplantation immunity: does 23+17 equal rejection?. Transplantation 2007, 84:1071-1074.
36. Ohteki T., Parsons M., Zakarian A., Jones R.G., Nguyen L.T., Woodgett J.R., Ohashi P.S. Negative regulation of T cell proliferation and interleukin 2 production by the serine threonine kinase GSK-3. The Journal of Experimental Medicine 2000, 192:99-104.
37. Appleman L.J., van Puijenbroek A.A., Shu K.M., Nadler L.M., Boussiotis V.A. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells. Journal of Immunology 2002, 168:2729-2736.
38. Chen G., Sun H., Arp J., Garcia B., Wang X., Wise Y., Liu W., Ramcharran S., Huang X., Xiang Y., Yang H., Fang Z., Madrenas J., Sudo Y., Tamura K., Zhong R. A synergistic effect between PG490-88 and tacrolimus prolongs renal allograft survival in monkeys. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2006, 6:714-723.
39. Ueno T., Yamada A., Ito T., Yeung M.Y., Gorbatov R., Shimizu T., Abdi R., Sayegh M.H., Auchincloss H., Najafian N. Role of nuclear factor of activated T cell (NFAT) transcription factors in skin and vascularized cardiac allograft rejection. Transplantation 2011, 92:e26-27.
40. Kobayashi A., Takahashi T., Horita S., Yamamoto I., Yamamoto H., Teraoka S., Tanabe K., Hosoya T., Yamaguchi Y. Activation of the transcription factor c-Jun in acute cellular and antibody-mediated rejection after kidney transplantation. Human Pathology 2010, 41:1682-1693.
41. Csizmadia V., Gao W., Hancock S.A., Rottman J.B., Wu Z., Turka L.A., Siebenlist U., Hancock W.W. Differential NF-kappaB and IkappaB gene expression during development of cardiac allograft rejection versus CD154 monoclonal antibody-induced tolerance. Transplantation 2001, 71:835-840.
42. Beals C.R., Sheridan C.M., Turck C.W., Gardner P., Crabtree G.R. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 1997, 275:1930-1934.
43. Murphy L.L., Hughes C.C. Endothelial cells stimulate T cell NFAT nuclear translocation in the presence of cyclosporin A: involvement of the wnt/glycogen synthase kinase-3 beta pathway. Journal of Immunology 2002, 169:3717-3725.
44. Escribano C., Delgado-Martin C., Rodriguez-Fernandez J.L. CCR7-dependent stimulation of survival in dendritic cells involves inhibition of GSK3beta. Journal of Immunology 2009, 183:6282-6295.